Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Infusion related reaction
ADR ID BADD_A05064
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.03      General signs and symptoms NEC
08.01.03.002      Infusion related reaction
10      Immune system disorders
10.01      Allergic conditions
10.01.01      Allergies to foods, food additives, drugs and other chemicals
10.01.01.017      Infusion related reaction
12      Injury, poisoning and procedural complications
12.02      Procedural related injuries and complications NEC
12.02.05      Non-site specific procedural complications
12.02.05.009      Infusion related reaction
Description A disorder characterized by adverse reaction to the infusion of pharmacological or biological substances. [CTCAE]
MedDRA Code 10051792
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Infusion associated symptoms | Infusion related reaction | Infusion associated sensation of cold | Infusion associated chills | Infusion associated shivering | Infusion associated discomfort | Infusion related pain | Infusion reaction | Infusion related fever | Infusion related hypotension
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00012Abatacept--
BADD_D00046Ado-trastuzumab emtansine--
BADD_D00049Agalsidase beta--
BADD_D00132Amphotericin b--
BADD_D00143Anidulafungin--
BADD_D00231Bendamustine hydrochloride--
BADD_D00282Blinatumomab--
BADD_D00349Capecitabine--
BADD_D00367Carfilzomib--
BADD_D00422Cetuximab--
BADD_D00573Dalbavancin hydrochloride--
BADD_D00582Daratumumab--
BADD_D00685Dinutuximab--
BADD_D01001Galsulfase--
BADD_D01007Gazyva--
BADD_D01015Gemtuzumab ozogamicin--
BADD_D01124Icodextrin--
BADD_D01249Laronidase--
BADD_D01455Micafungin--
BADD_D01456Micafungin sodium--
BADD_D01581Nivolumab--
BADD_D01596Ofatumumab--
BADD_D01609Omacetaxine mepesuccinate--
BADD_D01623Oritavancin--
BADD_D01698Pegloticase--
BADD_D01700Pembrolizumab--
BADD_D01744Pertuzumab--
BADD_D01911Ramucirumab--
BADD_D01953Rituximab--
BADD_D02021Siltuximab--
The 1th Page    1 2    Next   Last    Total 2 Pages